WebJan 17, 2024 · Stratified analysis was performed according to biologic treatment lines. Multivariate analysis was performed adjusting for demographic variables, calendar year, metabolic syndrome, psoriatic arthritis, biologic treatment line, biologic naivety, co‐administration of oral treatments and previous oral systemic treatment exposure. WebJun 23, 2024 · Non-obesity was independently associated with PASI90 response at year 2 (p = 0.043), while biologic-naivety was independently associated with PASI90 responses at year 2 (p = 0.047) and year 3 (p = 0.021). An absolute PASI score of ≤3 was achieved by 82.2% and 80.0% of the patients at year 1 and year 5, respectively.
Long‐term efficacy and safety of ustekinumab for …
WebDec 1, 2016 · Biologic naivety and concomitant methotrexate intake were positive predictors for drug survival, whereas the female sex and the duration of previous systemic treatments were negative predictors.... WebApr 1, 2024 · Biologic naivety, high socioeconomic status, concomitant metabolic syndrome, and concomitant methotrexate use were significant positive predictors for biologic drug survival. Female sex, weight, use of TNFIs over UST, and duration of previous systemic treatments were significant predictors for treatment dropout (Table III ). can magma blocks start a fire
Drug survival in patients with psoriasis is associated with the ...
WebJul 4, 2024 · In multidimensional analysis statistically significant variables affecting risk of relapse were the following: biologic naivety (hazard ratio [HR] 0.707), ADA (HR 0.787), psoriasis area and severity index at the last follow-up visit (HR 1.049), abnormal hemoglobin level (HR 0.794), and abnormal lymphocyte counts (HR 1.278). WebJul 1, 2024 · The baseline patient characteristics associated with the effectiveness of biologics that were identified in previous studies were baseline BMI, baseline psoriasis activity and severity index (PASI), disease duration, and biological naivety 3, 4, 5, 6, 7. However, baseline BMI did not show significance in our study. WebMar 28, 2024 · From 22 February 2024, over a time-frame of 1 year, all adult psoriasis patients who were treated with biologics in the Department of Dermatology, Radboud University Medical Centre (Radboudumc), Nijmegen, the Netherlands were screened for a pragmatic dose-reduction strategy in patients with low, stable disease activity on the … can ma give tb test